Meet Doctor Jolly, Cardiac ...

Dr. Umjeet Jolly, MD, FRCPC

Claim this profile

St. Mary's General Hospital

Studies Heart Failure
Studies Congestive Heart Failure
5 reported clinical trials
8 drugs studied

Affiliated Hospitals

Image of trial facility.
Waterloo Wellington Cardiovascular Research Institute (WWCRI)
Image of trial facility.
St. Mary's Hospital

Clinical Trials Umjeet Jolly, MD, FRCPC is currently running

Image of trial facility.

WATCHMAN Device

for Atrial Fibrillation

LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
Recruiting1 award N/A3 criteria
Image of trial facility.

Remote Monitoring

for Pacemaker Management

While remote monitoring (RM) technology is currently available and has permitted surveillance and device assessment from any patient location, the use has been inconsistent in Canada, where only 8500 out of a potential 120 000 patients with cardiac implantable electronic devices (CIEDs) are enrolled in this program. This technology is in widespread use worldwide for all CIEDs but in Canada, it is utilized primarily for implantable defibrillators, but not pacemakers. Whereas most of the trials were designed to evaluate the efficacy of RM in implantable cardioverter defibrillator (ICD) patients, in the pacemaker (PM) population, there has been work performed already to demonstrate an increase in detection of frequency of adverse clinical events and a reduction in reaction time to those events by RM. Based on all the available literature, it appears that RM benefits both patients and healthcare systems. Overall, studies have demonstrated that RM can be used safely in all device patient-populations, with the exception of pacemaker-dependent patients. There have been no studies that have evaluated RM only follow up, nor have there been any studies evaluating pacemaker-dependent patients. This study that will safely assess the use of RM only, with in-clinic visits when necessary, that uses the patient-centered electronic platform developed by the Cardiac Arrhythmia Network of Canada (CANet) to perform PM follow up safely, in a more cost-effective manner.
Recruiting0 awards N/A2 criteria

More about Umjeet Jolly, MD, FRCPC

Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Umjeet Jolly, MD, FRCPC has experience with
  • Fixed AV Delay
  • SyncAV Programmed ON
  • WATCHMAN Device
  • Remote Monitoring
  • Remote Patient Management
  • Standard Of Care

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Umjeet Jolly, MD, FRCPC specialize in?
Is Umjeet Jolly, MD, FRCPC currently recruiting for clinical trials?
Are there any treatments that Umjeet Jolly, MD, FRCPC has studied deeply?
What is the best way to schedule an appointment with Umjeet Jolly, MD, FRCPC?
What is the office address of Umjeet Jolly, MD, FRCPC?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security